vs
Foghorn Therapeutics Inc.（FHTX）与Simulations Plus, Inc.（SLP）财务数据对比。点击上方公司名可切换其他公司
Simulations Plus, Inc.的季度营收约是Foghorn Therapeutics Inc.的2.0倍（$18.4M vs $9.2M），Simulations Plus, Inc.净利率更高（3.7% vs -234.3%，领先238.0%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs -2.7%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs 0.3%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
Simulations Plus公司为医药生物、化工、化妆品、食品原料及除草剂领域开发ADMET（吸收、分布、代谢、排泄和毒性）建模仿真软件，并于2014年9月收购了提供临床试验数据分析及咨询服务的Cognigen公司，助力相关行业研发工作开展。
FHTX vs SLP — 直观对比
营收规模更大
SLP
是对方的2.0倍
$9.2M
营收增速更快
FHTX
高出226.4%
-2.7%
净利率更高
SLP
高出238.0%
-234.3%
两年增速更快
FHTX
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $18.4M |
| 净利润 | $-21.7M | $676.0K |
| 毛利率 | — | 59.1% |
| 营业利润率 | -258.2% | 3.9% |
| 净利率 | -234.3% | 3.7% |
| 营收同比 | 223.8% | -2.7% |
| 净利润同比 | -11.1% | 228.2% |
| 每股收益（稀释后） | $-0.35 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXSLP
| Q4 25 | $9.2M | $18.4M | ||
| Q3 25 | $8.2M | $17.5M | ||
| Q2 25 | $7.6M | $20.4M | ||
| Q1 25 | $6.0M | $22.4M | ||
| Q4 24 | $2.9M | $18.9M | ||
| Q3 24 | $7.8M | $18.7M | ||
| Q2 24 | $6.9M | $18.5M | ||
| Q1 24 | $5.0M | $18.3M |
净利润FHTXSLP
| Q4 25 | $-21.7M | $676.0K | ||
| Q3 25 | $-15.8M | $-681.0K | ||
| Q2 25 | $-17.9M | $-67.3M | ||
| Q1 25 | $-18.8M | $3.1M | ||
| Q4 24 | $-19.5M | $206.0K | ||
| Q3 24 | $-19.1M | $843.0K | ||
| Q2 24 | $-23.0M | $3.1M | ||
| Q1 24 | $-25.0M | $4.0M |
毛利率FHTXSLP
| Q4 25 | — | 59.1% | ||
| Q3 25 | — | 56.4% | ||
| Q2 25 | — | 64.0% | ||
| Q1 25 | — | 58.5% | ||
| Q4 24 | — | 54.0% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 72.2% |
营业利润率FHTXSLP
| Q4 25 | -258.2% | 3.9% | ||
| Q3 25 | -226.9% | 3.8% | ||
| Q2 25 | -279.2% | -364.5% | ||
| Q1 25 | -385.0% | 12.1% | ||
| Q4 24 | -840.5% | 0.7% | ||
| Q3 24 | -305.5% | -6.2% | ||
| Q2 24 | -386.6% | 10.1% | ||
| Q1 24 | -558.3% | 24.3% |
净利率FHTXSLP
| Q4 25 | -234.3% | 3.7% | ||
| Q3 25 | -194.4% | -3.9% | ||
| Q2 25 | -237.3% | -330.6% | ||
| Q1 25 | -316.4% | 13.7% | ||
| Q4 24 | -682.9% | 1.1% | ||
| Q3 24 | -244.9% | 4.5% | ||
| Q2 24 | -333.6% | 16.9% | ||
| Q1 24 | -495.4% | 22.0% |
每股收益（稀释后）FHTXSLP
| Q4 25 | $-0.35 | $0.03 | ||
| Q3 25 | $-0.25 | $-0.03 | ||
| Q2 25 | $-0.28 | $-3.35 | ||
| Q1 25 | $-0.30 | $0.15 | ||
| Q4 24 | $-0.23 | $0.01 | ||
| Q3 24 | $-0.31 | $0.04 | ||
| Q2 24 | $-0.45 | $0.15 | ||
| Q1 24 | $-0.59 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $35.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $127.1M |
| 总资产 | $198.1M | $137.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXSLP
| Q4 25 | $80.9M | $35.7M | ||
| Q3 25 | $89.3M | $32.4M | ||
| Q2 25 | $72.6M | $28.4M | ||
| Q1 25 | $61.0M | $21.4M | ||
| Q4 24 | $55.5M | $18.2M | ||
| Q3 24 | $57.7M | $20.3M | ||
| Q2 24 | $138.9M | $119.0M | ||
| Q1 24 | $79.3M | $108.5M |
股东权益FHTXSLP
| Q4 25 | $-108.5M | $127.1M | ||
| Q3 25 | $-89.7M | $124.8M | ||
| Q2 25 | $-76.7M | $123.8M | ||
| Q1 25 | $-61.7M | $189.5M | ||
| Q4 24 | $-45.5M | $184.7M | ||
| Q3 24 | $-28.3M | $182.4M | ||
| Q2 24 | $-14.3M | $180.9M | ||
| Q1 24 | $-97.5M | $177.0M |
总资产FHTXSLP
| Q4 25 | $198.1M | $137.8M | ||
| Q3 25 | $205.0M | $131.9M | ||
| Q2 25 | $226.2M | $134.4M | ||
| Q1 25 | $258.7M | $201.4M | ||
| Q4 24 | $284.0M | $196.9M | ||
| Q3 24 | $308.4M | $196.6M | ||
| Q2 24 | $328.6M | $192.7M | ||
| Q1 24 | $255.0M | $194.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | $4.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | 6.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXSLP
| Q4 25 | $-22.3M | $4.2M | ||
| Q3 25 | $-18.9M | $5.6M | ||
| Q2 25 | $-21.0M | $8.1M | ||
| Q1 25 | $-24.0M | $5.7M | ||
| Q4 24 | $-24.5M | $-1.3M | ||
| Q3 24 | $-21.0M | $1.7M | ||
| Q2 24 | $-25.5M | $5.7M | ||
| Q1 24 | $-29.3M | $5.8M |
自由现金流FHTXSLP
| Q4 25 | — | — | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | $-21.0M | $7.8M | ||
| Q1 25 | $-24.0M | $5.6M | ||
| Q4 24 | $-25.0M | $-1.4M | ||
| Q3 24 | $-21.3M | $1.6M | ||
| Q2 24 | $-25.6M | $5.6M | ||
| Q1 24 | $-29.4M | $5.4M |
自由现金流率FHTXSLP
| Q4 25 | — | — | ||
| Q3 25 | — | 30.5% | ||
| Q2 25 | -278.2% | 38.5% | ||
| Q1 25 | -403.2% | 25.0% | ||
| Q4 24 | -875.3% | -7.2% | ||
| Q3 24 | -273.0% | 8.8% | ||
| Q2 24 | -371.0% | 30.0% | ||
| Q1 24 | -583.1% | 29.4% |
资本支出强度FHTXSLP
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 1.5% | ||
| Q2 25 | 0.3% | 1.5% | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 16.8% | 0.5% | ||
| Q3 24 | 4.0% | 0.1% | ||
| Q2 24 | 0.2% | 0.6% | ||
| Q1 24 | 2.0% | 2.4% |
现金转化率FHTXSLP
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.84× | ||
| Q4 24 | — | -6.18× | ||
| Q3 24 | — | 1.97× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHTX
暂无分部数据
SLP
| Services Segment | $9.5M | 52% |
| Development | $7.2M | 39% |
| Discovery | $1.3M | 7% |
